Canopy Growth Corp T.WEED

DSG, Inc. Partners with Bedrocan Canada to Evaluate Patients

[Robinbrook]

DSG, Inc. Partners with Bedrocan Canada and Tweed in a Non-Interventional Unblinded Study to Evaluate Quality of Life in Patients Treated with Medical Marijuana

MALVERN, Pa.--(BUSINESS WIRE)--DSG, a leader in electronic data capture (EDC), has teamed up with Canada’s leading licensed producers of medical grade marijuana, Bedrocan Canada Inc. and Tweed Inc., subsidiaries of Tweed Marijuana Inc., to provide EDC and Electronic Patient Reported Outcomes (ePRO) services for the companies’ current large-scale in-country clinical study, the largest of its kind. The primary objective of the study, which is intended to continue for three years, include more than 50 sites, and enroll up to 6,000 patients, is to evaluate the quality of life (QoL) of patients before and after treatment with medical cannabis. eCaseLink significantly increases clinical trial management speed while reducing study management cost. A truly integrated solution, DSG’s eCaseLink seamlessly combines EDC, ePRO, Risk-Based Monitoring, eSource, IWRS Randomization-Clinical Supply, Drug Safety, Site Payments and CTMSinto a single harmonized system. DSG’s clinical study build tool makes initial EDC startup intuitive and fast, with unparalleled support services and hands-on training for self-build studies, used also by DSG’s team in providing full service SaaS software systems.

https://www.nationalpost.com/news/business-wire/detail.html?b=www.businesswire.com%2Fnews%2Fsyndication%2F20160216005393%2Fen%2FDSG-Partners-Bedrocan-Canada-Tweed-Non-Interventional-Unblinded